Purchases and Sales Made in Q1 2023 in Kymera Therapeutics, Inc. (KYMR)
This table provides information about the institutional ownership of Kymera Therapeutics, Inc. (KYMR) during Q1 2023. The information is specifically focused on institutions that hold shares of Kymera Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2023
Q1 2023
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-36.8K- 70.33% |
$914K - $1.43M
|
15.5K
$630K
|
|
|
May 11, 2023
Q1 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-41.1K- 12.16% |
$1.02M - $1.59M
|
297K
$12.1M
|
|
|
May 14, 2024
Q1 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-41.1K- 12.16% |
$1.02M - $1.59M
|
297K
$12.1M
|
|
|
May 15, 2023
Q1 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-119K- 4.19% |
$2.97M - $4.63M
|
2.73M
$111M
|
|
|
May 15, 2023
Q1 2023
|
Atlas Venture Life Science Advisors, LLC
|
SELL
|
- |
-126K- 2.11% |
$3.14M - $4.9M
|
5.86M
$238M
|
|
|
May 12, 2023
Q1 2023
|
Artal Group S.A.
Luxembourg, N4 |
SELL
|
- |
-195K- 9.73% |
$4.84M - $7.54M
|
1.81M
$73.3M
|
|
|
May 15, 2023
Q1 2023
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-263K- 9.84% |
$6.53M - $10.2M
|
2.41M
$97.9M
|
|
|
May 12, 2023
Q1 2023
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-300K- 6.54% |
$7.45M - $11.6M
|
4.29M
$174M
|